WebCarboplatin-paclitaxel is an active combination in advanced and recurrent cervical cancer. ... advanced or recurrent carcinoma of the cervix treated with carboplatin-paclitaxel from April 2000 were included in the study. Starting doses of carboplatin-paclitaxel were: AUC 5-6 and 155-175 mg/m(2), ... WebMay 25, 2024 · TPS6096 Background: High-risk locally advanced cervical cancer has a poor prognosis, and more than half of patients recur in 2 y. External beam radiotherapy (EBRT) with concurrent chemotherapy followed by brachytherapy is the standard of care for locally advanced cervical cancer. The immunostimulatory activity of the PD-1 inhibitor …
ANZGOG’S OUTBACK TRIAL AMONG THE MOST IMPORTANT …
WebAug 12, 2024 · OUTBACK was an international, randomized phase III trial evaluating concurrent chemoradiation (CRT) either alone or followed by 4 additional cycles of … WebJun 14, 2024 · Of note, while the trial was ongoing, many clinicians adopted the use of “outback” adjuvant chemotherapy into clinical care. The study reported several important … neon lights torrent
Adjuvant chemotherapy following chemoradiation as primary …
WebNov 13, 2024 · For cancer information and support, call Cancer Council's experienced cancer nurses on 13 11 20 Monday to Friday from 9am-5pm. Home > Trial Details OUTBACK : A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK … WebJun 9, 2024 · The current standard of care of CRT dates back to a 1999 National Cancer Institute clinical alert. 1 A 2008 meta-analysis and a 2011 study suggested patients could … WebCervix Cancer Research Network: The OUTBACK trial • Multi-centre phase III trial • International, Cooperative group study • Led by ANZGOG • Coordinated at the NHMRC Clinical Trials Centre (CTC), the University of Sydney Cervix Cancer Education Symposium, January 2024, Mexico. neon lights prom theme